11/21
07:52 am
bctx
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study [Yahoo! Finance]
High
Report
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study [Yahoo! Finance]
11/21
07:50 am
bctx
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study
High
Report
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study
11/8
11:28 am
bctx
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference [Canadian Business Journal (Canada)]
Low
Report
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference [Canadian Business Journal (Canada)]
11/8
07:55 am
bctx
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference [Yahoo! Finance]
Medium
Report
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference [Yahoo! Finance]
11/8
07:50 am
bctx
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
Medium
Report
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
11/4
08:06 am
bctx
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 [Yahoo! Finance]
Low
Report
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 [Yahoo! Finance]
11/4
07:50 am
bctx
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
Low
Report
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
10/22
02:56 pm
bctx
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns [Seeking Alpha]
Low
Report
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns [Seeking Alpha]
10/22
07:50 am
bctx
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
High
Report
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
10/15
10:54 am
bctx
BriaCell gains after update on late-stage trial for lead asset [Seeking Alpha]
Medium
Report
BriaCell gains after update on late-stage trial for lead asset [Seeking Alpha]
10/15
08:01 am
bctx
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study [Yahoo! Finance]
Low
Report
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study [Yahoo! Finance]
10/15
07:50 am
bctx
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
Low
Report
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
10/3
08:18 am
bctx
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/2
05:22 pm
bctx
BriaCell Therapeutics Announces Closing of $5 Million Offering [Yahoo! Finance Canada]
Low
Report
BriaCell Therapeutics Announces Closing of $5 Million Offering [Yahoo! Finance Canada]
10/2
04:26 pm
bctx
BriaCell Therapeutics Announces $5 Million Offering [Yahoo! Finance Canada]
Low
Report
BriaCell Therapeutics Announces $5 Million Offering [Yahoo! Finance Canada]
10/2
04:26 pm
bctx
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor [Yahoo! Finance Canada]
Low
Report
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor [Yahoo! Finance Canada]
10/2
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of $5 Million Offering
Low
Report
BriaCell Therapeutics Announces Closing of $5 Million Offering
10/1
02:05 pm
bctx
BriaCell Therapeutics Announces $5 Million Offering
Medium
Report
BriaCell Therapeutics Announces $5 Million Offering
10/1
07:55 am
bctx
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor [Yahoo! Finance]
High
Report
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor [Yahoo! Finance]
10/1
07:50 am
bctx
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
High
Report
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
9/19
08:08 am
bctx
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its price target lowered by analysts at HC Wainwright from $18.00 to $15.00. They now have a "buy" rating on the stock.
Medium
Report
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its price target lowered by analysts at HC Wainwright from $18.00 to $15.00. They now have a "buy" rating on the stock.
9/18
07:50 am
bctx
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
Medium
Report
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
9/12
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of $8.5 Million Offering
Medium
Report
BriaCell Therapeutics Announces Closing of $8.5 Million Offering
9/11
01:29 pm
bctx
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
9/11
12:23 pm
bctx
BriaCell Therapeutics Announces $8.5 Million Offering [Yahoo! Finance]
High
Report
BriaCell Therapeutics Announces $8.5 Million Offering [Yahoo! Finance]